Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Evolocumab on Chronic Total Occlusions After Successful Percutaneous Coronary Intervention (EVOLO-CTO)

NCT05623995 is registered in ClinicalTrials.gov with Lin Zhao as lead sponsor.

NCT NCT05623995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05623995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Evolocumab on Chronic Total Occlusions After Successful Percutaneous Coronary Intervention (EVOLO-CTO)
Lead sponsor
Lin Zhao
Phase
Phase 4
Overall status
Unknown status
Start date
December 15, 2022
Completion date
December 1, 2025
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

in-stent restenosis, major adverse cardiovascular events